64 related articles for article (PubMed ID: 2959046)
1. Pharmacology of synthetic thromboxane A2.
Bunting S; Buchanan LV; Holzgrefe HH; Fitzpatrick FA
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():192-8. PubMed ID: 2959046
[No Abstract] [Full Text] [Related]
2. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
[No Abstract] [Full Text] [Related]
3. In vivo characterization of synthetic thromboxane A2 in canine myocardium.
Holzgrefe HH; Buchanan LV; Bunting S
Circ Res; 1987 Feb; 60(2):290-6. PubMed ID: 3568297
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary pharmacology of synthetic thromboxane A2.
Richards IM; Oostveen JA; Griffin RL; Bunting S
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1067-72. PubMed ID: 2960147
[No Abstract] [Full Text] [Related]
5. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
Whittle BJ; Kauffman GL; Moncada S
Nature; 1981 Jul; 292(5822):472-4. PubMed ID: 7195986
[No Abstract] [Full Text] [Related]
6. A structural analog of thromboxane A2.
Ansell MF; Caton MP; Palfreyman MN; Stuttle KA; Tuffin D; Walker JL
Adv Prostaglandin Thromboxane Res; 1980; 6():485-7. PubMed ID: 7386282
[No Abstract] [Full Text] [Related]
7. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
Nicolaou KC; Magolda RL
Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
[No Abstract] [Full Text] [Related]
8. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
9. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
[No Abstract] [Full Text] [Related]
10. Preventive effect of ONO-3708 on thrombosis and vasospasms in vitro and in vivo.
Kondo K; Seo R; Kitagawa T; Omawari N; Kira H; Okegawa T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():423-6. PubMed ID: 2959089
[No Abstract] [Full Text] [Related]
11. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog.
Carrier M; Tronc F; Pelletier LC; Latour JG
J Heart Lung Transplant; 1993; 12(5):851-5. PubMed ID: 8241227
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
Hamanaka N; Ohuchida S; Hayashi M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():319-22. PubMed ID: 6221543
[No Abstract] [Full Text] [Related]
13. Pharmacology of thromboxane synthetase inhibitors.
Smith JB
Fed Proc; 1987 Jan; 46(1):139-43. PubMed ID: 3542573
[TBL] [Abstract][Full Text] [Related]
14. ONO-3708: an effective thromboxane A2 antagonist possessing 3-acylaminopinane skeleton.
Suga H; Hamanaka N; Kondo K; Miyake H; Ohuchida S; Arai Y; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():799-802. PubMed ID: 2960194
[No Abstract] [Full Text] [Related]
15. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
Fitzpatrick T; Harris R; Ramwell P; Kot P
Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
[No Abstract] [Full Text] [Related]
16. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
17. Developments of TXA2 antagonists.
Hamanaka N
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():663-5. PubMed ID: 2526556
[No Abstract] [Full Text] [Related]
18. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
Verheggen R; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S264-7. PubMed ID: 3248112
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
20. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
Fuse I; Hattori A; Mito M; Higuchi W; Yahata K; Shibata A; Aizawa Y
Thromb Haemost; 1996 Dec; 76(6):1080-5. PubMed ID: 8972034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
